Niraparib Exposure-Response Relationship In Patients (Pts) With Newly Diagnosed Advanced Ovarian Cancer (Aoc).

Bradley J. Monk,Ignacio Romero,Whitney Graybill,Cristina Churruca,David M. O'Malley,Bente Lund, Oi Wah S. Yap,Jean-Francois Baurain,Peter Graham Rose,Hannelore denys,Sharad A. Ghamande,Carmela Pisano,Michel Fabbro,Elena Ioana Braicu,Paula Calvert,Amnon Amit,Emily Prendergast,Ashley Milton,Zhi-Yi Zhang,Antonio Gonzalez Martin

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 2|浏览73

暂无评分

摘要

6051Background: Niraparib improves progression-free survival (PFS) in pts with newly diagnosed AOC after complete or partial response to first-line, platinum-based chemotherapy. In the PRIMA/ENGOT-...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要